↓ Skip to main content

Real-World Use of Talimogene Laherparepvec in German Patients with Stage IIIB to IVM1a Melanoma: A Retrospective Chart Review and Physician Survey

Overview of attention for article published in Advances in Therapy, December 2018
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (51st percentile)
  • Above-average Attention Score compared to outputs of the same age and source (55th percentile)

Mentioned by

twitter
5 X users

Citations

dimensions_citation
18 Dimensions

Readers on

mendeley
31 Mendeley
Title
Real-World Use of Talimogene Laherparepvec in German Patients with Stage IIIB to IVM1a Melanoma: A Retrospective Chart Review and Physician Survey
Published in
Advances in Therapy, December 2018
DOI 10.1007/s12325-018-0850-6
Pubmed ID
Authors

Peter Mohr, Sebastian Haferkamp, Andreas Pinter, Carsten Weishaupt, Margit A. Huber, Gerald Downey, Katarina Öhrling, Carmen Loquai, Karly S. Louie

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 31 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 31 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 3 10%
Other 2 6%
Professor 2 6%
Student > Master 2 6%
Student > Ph. D. Student 2 6%
Other 4 13%
Unknown 16 52%
Readers by discipline Count As %
Medicine and Dentistry 8 26%
Pharmacology, Toxicology and Pharmaceutical Science 2 6%
Biochemistry, Genetics and Molecular Biology 2 6%
Nursing and Health Professions 1 3%
Sports and Recreations 1 3%
Other 1 3%
Unknown 16 52%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 December 2018.
All research outputs
#13,396,521
of 23,117,738 outputs
Outputs from Advances in Therapy
#975
of 2,385 outputs
Outputs of similar age
#208,592
of 436,549 outputs
Outputs of similar age from Advances in Therapy
#23
of 52 outputs
Altmetric has tracked 23,117,738 research outputs across all sources so far. This one is in the 41st percentile – i.e., 41% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,385 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.4. This one has gotten more attention than average, scoring higher than 58% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 436,549 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 51% of its contemporaries.
We're also able to compare this research output to 52 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 55% of its contemporaries.